Cell membrane chromatography (CMC)
derived from pathological tissues
is ideal for screening specific components acting on specific diseases
from complex medicines owing to the maximum simulation of in vivo drug-receptor interactions. However, there are no
pathological tissue-derived CMC models that have ever been developed,
as well as no visualized affinity comparison of potential active components
between normal and pathological CMC columns. In this study, a novel
comparative normal/failing rat myocardium CMC analysis system based
on online column selection and comprehensive two-dimensional (2D)
chromatography/monolithic column/time-of-flight mass spectrometry
was developed for parallel comparison of the chromatographic behaviors
on both normal and pathological CMC columns, as well as rapid screening
of the specific therapeutic agents that counteract doxorubicin (DOX)-induced
heart failure from Acontium carmichaeli (Fuzi). In
total, 16 potential active alkaloid components with similar structures
in Fuzi were retained on both normal and failing myocardium CMC models.
Most of them had obvious decreases of affinities on failing myocardium
CMC compared with normal CMC model except for four components, talatizamine
(TALA), 14-acetyl-TALA, hetisine, and 14-benzoylneoline. One compound
TALA with the highest affinity was isolated for further in
vitro pharmacodynamic validation and target identification
to validate the screen results. Voltage-dependent K+ channel
was confirmed as a binding target of TALA and 14-acetyl-TALA with
high affinities. The online high throughput comparative CMC analysis
method is suitable for screening specific active components from herbal
medicines by increasing the specificity of screened results and can
also be applied to other biological chromatography models.